1. Home
  2. MDGL vs LPX Comparison

MDGL vs LPX Comparison

Compare MDGL & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • LPX
  • Stock Information
  • Founded
  • MDGL 2011
  • LPX 1973
  • Country
  • MDGL United States
  • LPX United States
  • Employees
  • MDGL N/A
  • LPX N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • LPX Forest Products
  • Sector
  • MDGL Health Care
  • LPX Basic Materials
  • Exchange
  • MDGL Nasdaq
  • LPX Nasdaq
  • Market Cap
  • MDGL 6.1B
  • LPX 6.2B
  • IPO Year
  • MDGL N/A
  • LPX N/A
  • Fundamental
  • Price
  • MDGL $314.31
  • LPX $92.89
  • Analyst Decision
  • MDGL Strong Buy
  • LPX Buy
  • Analyst Count
  • MDGL 9
  • LPX 8
  • Target Price
  • MDGL $420.63
  • LPX $106.88
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • LPX 943.9K
  • Earning Date
  • MDGL 08-06-2025
  • LPX 08-06-2025
  • Dividend Yield
  • MDGL N/A
  • LPX 1.20%
  • EPS Growth
  • MDGL N/A
  • LPX 56.47
  • EPS
  • MDGL N/A
  • LPX 5.71
  • Revenue
  • MDGL $317,383,000.00
  • LPX $2,941,000,000.00
  • Revenue This Year
  • MDGL $286.17
  • LPX N/A
  • Revenue Next Year
  • MDGL $64.17
  • LPX $7.05
  • P/E Ratio
  • MDGL N/A
  • LPX $16.36
  • Revenue Growth
  • MDGL N/A
  • LPX 8.09
  • 52 Week Low
  • MDGL $200.63
  • LPX $78.82
  • 52 Week High
  • MDGL $377.46
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • LPX 55.70
  • Support Level
  • MDGL $284.02
  • LPX $88.71
  • Resistance Level
  • MDGL $311.21
  • LPX $97.62
  • Average True Range (ATR)
  • MDGL 11.94
  • LPX 2.67
  • MACD
  • MDGL 2.74
  • LPX 0.67
  • Stochastic Oscillator
  • MDGL 100.00
  • LPX 62.52

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: